The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal
Official Title: Stereotactic Radiotherapy for Cerebral Metastases With Recent Hemorrhagic Signal: Phase 2 Study in 2 Steps
Study ID: NCT03696680
Brief Summary: This prospective 2-stage, non-randomized Phase 2 trial evaluates the safety and efficacy of FSRT for the management of hemorrhagic brain metastases
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre de la Baie, Avranches, , France
Centre François Baclesse, Caen, , France
Institut de Cancérologie de Lorraine, Nancy, , France